Amgen Inc
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$465.45−0.56 (-0.12%)
Close on Nov 2, 2026Market cap $251.64BP/E 28.9Yield 2.08%
Amgen Other Segment Items by Year
Other Segment Items (Other Operating Expenses & Non-Core Items) ($M) ($M)
Amgen Other Segment Items: -$931M in FY2025, down 469.4% from a year earlier.
Latest, FY2025
-931
Period ended Dec 31, 2025
Change on a year earlier
-469.4%
252 in FY2024
History
4 years
Since FY2022
Sources
2
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-13) ↗
Reported in Form 10-Q / 10-K Note 2 Segment Expense Disaggregation (XBRL).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Other Segment Items (Other Operating Expenses & Non-Core Items) ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | -931 | -469.4% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | 252 | -134.6% | Form 10-K (filed 2026-02-13) ↗ |
| FY2023 | Dec 31, 2023 | -729 | -193.8% | Form 10-K (filed 2026-02-13) ↗ |
| FY2022 | Dec 31, 2022 | 777 | – | Form 10-K (filed 2025-02-14) ↗ |
Cite this data
StockData. (2026). Amgen Other Segment Items ($M), annual FY2022–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/seg-other-exp
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.